✦ LIBER ✦

Chemotherapy of advanced salivary gland neoplasms

✍ Scribed by Marshall R. Posner; Thomas J. Ervin; Ralph R. Weichselbaum; Richard L. Fabian; Daniel Miller

Publisher: John Wiley and Sons
Year: 1982
Tongue: English
Weight: 340 KB
Volume: 50
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19821201)50:11<2261::aid-cncr2820501105>3.0.co;2-e

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Preliminary experience with chemotherapy

Preliminary experience with chemotherapy in advanced salivary gland neoplasms

✍ Belani, Chandra P. ;Eisenberger, Mario A. ;Gray, William C. 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 390 KB

Eight patients with advanced incurable salivary gland carcinoma were treated with the combination of cyclophosphamide, doxorubicin, and cisplatin (CAP). There were three clinical complete responses and two excellent partial responses. One of the three nonresponders had symptomatic improvement withou

Recurrent malignant salivary gland neopl

Recurrent malignant salivary gland neoplasms

✍ M. A. Rodriguez-Bigas; Dr. K. Sako; M. S. Razack; D. P. Shedd; V. Y. Bakamjian; 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 373 KB

Recurrent salivary gland malignancies present difficult therapeutic decisions and poor prognosis in many instances, and treatment becomes of a palliative nature only. As many of the salivary gland malignancies we see are of the recurrent type, the following study was done to determine the efficacy o

Malignant neoplasms of the major salivar

Malignant neoplasms of the major salivary glands

✍ W. Thomas Lawrence; Walter Lawrence 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 English ⚖ 685 KB

## Abstract Between January 1, 1968 and December 31, 1978, 42 patients with malignant lesions involving the major salivary glands were seen at the Medical College of Virginia. A 60% 2‐year survival and a 42% 5‐year survival were noted. Histologic type was the major determinant of survival. Symptoms

Salivary gland malignant neoplasms: Trea

Salivary gland malignant neoplasms: Treatment and prognosis

✍ Arne Borthne; Kjell Kjellevold; Olav Kaalhus; Halvor Vermund 📂 Article 📅 1986 🏛 Elsevier Science 🌐 English ⚖ 958 KB

Cyclophosphamide, doxorubicin, and cispl

Cyclophosphamide, doxorubicin, and cisplatin combination chemotherapy for advanced carcinomas of salivary gland origin

✍ Arnon I. Dreyfuss; John R. Clark; Barbara G. Fallon; Marshall R. Posner; Charles 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 408 KB 👁 2 views

Thirteen patients with carcinomas of major and minor salivary gland origin (nine adenoid cystic carcinomas and four adenocarcinomas) were treated with cyclophosphamide (500 mg/m2), doxorubicin (50 mg/m2), and cisplatin (50 mg/m2) (CAP) by intravenous injections on the first day of a 28-day regimen.

Accuracy of frozen-section diagnosis in

Accuracy of frozen-section diagnosis in salivary gland neoplasms

✍ Rigual, Néstor R. ;Milley, Paul ;Loré, John M. ;Kaufman, Sol 📂 Article 📅 1986 🏛 Wiley (John Wiley & Sons) ⚖ 400 KB

A retrospective review of 100 patients with major or minor salivary gland neoplasms was conducted to ascertain the accuracy and effect on therapy of frozen-section diagnosis. Of these patients, 23% had malignant and 77% benign neoplasms. Twelve patients benefited by further surgery during the initia